Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Baudax Bio, Inc. (BXRX)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | |
| Cost of goods sold | 4577.0% | 1859.8% | 15269.6% | 69.1% | |
| Gross profit | -4477.0% | -1759.8% | -15169.6% | 30.9% | |
| Selling, general and administrative | 0.0% | 0.0% | 0.0% | 57.4% | |
| Research and development | | | | 42.6% | |
| General and administrative | 0.0% | 0.0% | 0.0% | | |
| Depreciation | | | | 1.0% | |
| EBIT | -4789.9% | -1906.5% | -12032.7% | -69.1% | |
| Pre-tax income | -4633.2% | -1830.5% | -15436.1% | -69.2% | |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | |
| Net income | -4633.2% | -1830.5% | -15436.1% | -69.2% | |
|